105
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Analgesic efficacy of CR4056, a novel imidazoline-2 receptor ligand, in rat models of inflammatory and neuropathic pain

, , , , , , , & show all
Pages 111-125 | Published online: 18 Apr 2011

References

  • MolderingsGJImidazoline receptors: basic knowledge, recent advances, and future prospects for therapy and diagnosisDrug Future199722757772
  • PiletzJEIvanovTRSharpJDImidazoline receptor antisera-selected (IRAS) cDNA: cloning and characterizationDNA Cell Biol20001931932910882231
  • BousquetPIdentification and characterization of I1 imidazoline receptors: their role in blood pressure regulationAm J Hypertens20001384S88S10921526
  • TessonFLimon-BoulezIUrbanPLocalization of I2-imidazoline binding sites on monoamine oxidasesJ Biol Chem1995270985698617730367
  • CarpénéCCollonPRemauryAInhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sitesJ Pharmacol Exp Ther19952726816887853182
  • OzaitaAOlmosGBoronatMALizcanoJMUnzetaMGarcía-SevillaJAInhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liverBr J Pharmacol19971219019129222546
  • McDonaldGROlivieriARamsayRRHoltAOn the formation and nature of the imidazoline I2 binding site on human monoamine oxidase-BPharmacol Res201062647548820832472
  • KimuraATyackeRJRobinsonJJIdentification of an imidazoline binding protein: creatine kinase and an imidazoline-2 binding siteBrain Res20091279212819410564
  • HoltASmithDJCendronLZanottiGRigoADi PaoloMLMultiple binding sites for substrates and modulators of semicarbazide-sensitive amine oxidases: kinetic consequencesMol Pharmacol20087352553817989349
  • García-SevillaJAEscribáPVSastreMImmunodetection and quantitation of imidazoline receptor proteins in platelets of patients with major depression and in brains of suicide victimsArch Gen Psychiatry1996538038108792757
  • García-SevillaJAEscribáPVWalzerCBourasCGuimónJImidazoline receptor proteins in brains of patients with Alzheimer’s diseaseNeurosci Lett199824795989655601
  • PiletzJEZhuHOrdwayGImidazoline receptor proteins are decreased in the hippocampus of individuals with major depressionBiol Psychiatry20004891091911074229
  • BoronatMAOlmosGGarcía-SevillaJAAttenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligandsBr J Pharmacol19981251751859776358
  • FairbanksCASchreiberKLBrewerKLAgmatine reverses pain induced by inflammation, neuropathy, and spinal cord injuryProc Natl Acad Sci200097105841058910984543
  • AriciogluFKorcegezEBozkurtAOzyalcinSEffect of agmatine on acute and mononeuropathic painAnn N Y Acad Sci2003100910611515028574
  • GentiliFCardinalettiCCarrieriAInvolvement of I2-imidazoline binding sites in positive and negative morphine analgesia modulatory effectsEur J Pharmacol2006553738117081513
  • WuNSuRBLiJAgmatine and imidazoline receptors: their role in opioid analgesia, tolerance and dependenceCell Mol Neurobiol20082862964117653850
  • Ruiz-DurantezETorrecillaMPinedaJUgedoLAttenuation of acute and chronic effects of morphine by the imidazoline receptor ligand 2-(2-benzofuranyl)-2-imidazoline in rat locus coeruleus neuronsBr J Pharmacol200313849450012569074
  • BennettMIEffectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: systematic reviewPalliat Med201010.1177/0269216310378546
  • FinnerupNBSindrupSHJensenTSThe evidence for pharmacological treatment of neuropathic painPain201015057358120705215
  • CesuraAMGalvaMDImhofRKyburzEPicottiGBDaPradaM[3H]Ro 19-6327: a reversible ligand and affinity labelling probe for monoamine oxidase-BEur J Pharmacol19891624574652744079
  • CesuraAMBosMGalvaMDImhofRDaPradaMCharacterization of the binding of [3H]Ro 41-1049 to active site of human monoamine oxidase-AMol Pharmacol1990373583662314388
  • KimSHSongJMunHParkKUEffect of the combined use of tramadol and milnacipran on pain threshold in an animal model of fibromyalgiaKorean J Intern Med20092413914219543493
  • NielsenANMathiesenCBlackburn-MunroGPharmacological characterisation of acid-induced muscle allodynia in ratsEur J Pharmacol20044879310315033380
  • HwangSLLiuIMTzengTFChengJTActivation of imidazoline receptors in adrenal gland to lower plasma glucose in streptozotocin-induced diabetic ratsDiabetologia20054876777515756537
  • ChangCHWuHTChengKCLinHJChengJTIncrease of beta-endorphin secretion by agmatine is induced by activation of imidazoline I(2A) receptors in adrenal gland of ratsNeurosci Lett201046829729919913596
  • Ruiz-DurántezERuiz-OrtegaJAPinedaJUgedoLEffect of agmatine on locus coeruleus neuron activity: possible involvement of nitric oxideBr J Pharmacol20021351152115811877321
  • RawlsSMTallaridaRJZiskJAgmatine and a cannabinoid agonist, WIN 55212-2, interact to produce a hypothermic synergyEur J Pharmacol2006553899817109846
  • AggarwalSShavalianBKimERawlsSMAgmatine enhances cannabinoid action in the hot-plate assay of thermal nociceptionPharmacol Biochem Behav20099342643219538988
  • MacInnesNHandleySLRegion-dependent effects of acute and chronic tranylcypromine in vivo on [3H]2-BFI binding to brain imidazoline I2 sitesEur J Pharmacol200142822122511675039
  • JasminLTienDJanniGOharaPTIs noradrenaline a significant factor in the analgesic effect of antidepressants?Pain20031063814581104
  • PertovaaraANoradrenergic pain modulationProg Neurobiol200680538317030082
  • FinnerupNBA review of central neuropathic pain statesCurr Opin Anaesthesiol20082158658918784483
  • BannisterKBeeLADickensonAHPreclinical and early clinical investigations related to monoaminergic pain modulationNeurotherapeutics2009670371219789074
  • OssipovMHLaiJMalanTPPorrecaFSpinal and supraspinal mechanisms of neuropathic painAnn N Y Acad Sci2000909122410911921
  • DubnerRThe neurobiology of persistent pain and its clinical implicationsSuppl Clin Neurophysiol2004573716106600
  • BrightwellJJTaylorBKNoradrenergic neurons in the locus coeruleus contribute to neuropathic painNeuroscience200916017418519223010
  • DworkinRHO’ConnorABBackonjaMPharmacologic management of neuropathic pain: evidence-based recommendationsPain200713223725117920770
  • MarksDMShahMJPatkarAAMasandPSParkG-YPaeC-USerotonin-norepinephrine reuptake inhibitors for pain control: premise and promiseCurr Neuropharmacol2009733133620514212
  • DinaOAKhasarSGAlessandri-HaberNNeurotoxic catecholamine metabolite in nociceptors contributes to painful peripheral neuropathyEur J Neurosci2008281180119018783367
  • NapierLDStanfillAYoshishigeDAJacksonKEBarronBACaffreyJLAutonomic control of heart rate in dogs treated chronically with morphineAm J Physiol1998275H2199H22109843820
  • McCrimmonDRAlheidGFOn the opiate trail of respiratory depressionAm J Physiol Regul Integr Comp Physiol2003285R1274R127514615398
  • Klein-SchwartzWTrends and toxic effects from pediatric clonidine exposuresArch Pediatr Adolesc Med200215639239611929375
  • SweetmanSMartindale: The Complete Drug Reference36th edLondonPharmaceutical Press2009
  • OlmosGAlemanyRGarcía-SevillaJAPharmacological and molecular discrimination of brain I2-imidazoline receptor subtypesNaunyn Schmiedebergs Arch Pharmacol19963547097168971730
  • SchlatterEAnkorina-StarkIHaxelmansSHohageHMoxonidine inhibits Na+/H+ exchange in proximal tubule cells and cortical collecting ductKidney Int1997524544599264001